Catch up on big investments and startups making waves in their communities in this week's The National Beat newsletter.
The FDA has approved an expanded indication for setmelanotide to treat children and adults with acquired hypothalamic obesity, Rhythm Pharmaceuticals announced. Setmelanotide (Imcivree, Rhythm ...
PVFARM has begun beta testing of its new tool, currently referred to as RE PILOT, for optimising solar layout decision-making.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results